{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:04:46Z","timestamp":1775469886690,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10067-023-06801-7","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T08:01:53Z","timestamp":1699257713000},"page":"325-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Low utilization of statins in patients with dermatomyositis\/polymyositis and hyperlipidemia: a multicenter USA-based study (2013\u20132023)"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-884X","authenticated-orcid":false,"given":"Joseph","family":"Fares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4615-4956","authenticated-orcid":false,"given":"Ross","family":"Summer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4113-2221","authenticated-orcid":false,"given":"Giorgos","family":"Loizidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"issue":"7404","key":"6801_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326(7404):1423","journal-title":"BMJ"},{"issue":"12","key":"6801_CR2","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3899\/jrheum.171389","volume":"45","author":"AM Jorge","year":"2018","unstructured":"Jorge AM, Lu N, Keller SF, Rai SK, Zhang Y, Choi HK (2018) The effect of statin use on mortality in systemic autoimmune rheumatic diseases. J Rheumatol 45(12):1689\u20131695","journal-title":"J Rheumatol"},{"key":"6801_CR3","unstructured":"Aminifar E, Tavakkol Afshari HS, Sathyapalan T, Abbasifard M, Sahebkar A (2013) The pleiotropic effects of statins in rheumatoid arthritis. J Pharm Pharmacol"},{"issue":"7","key":"6801_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/annrheumdis-2015-207714","volume":"75","author":"SR Schoenfeld","year":"2016","unstructured":"Schoenfeld SR, Lu L, Rai SK, Seeger JD, Zhang Y, Choi HK (2016) Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 75(7):1315\u20131320","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6801_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/ehjcvp\/pvab052","volume":"8","author":"S Rollefstad","year":"2022","unstructured":"Rollefstad S, Ikdahl E, Wibetoe G, Sexton J, Crowson CS, van Riel P et al (2022) An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries. Eur Heart J Cardiovasc Pharmacother 8(6):539\u2013548","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"1","key":"6801_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semarthrit.2014.03.004","volume":"44","author":"P Ungprasert","year":"2014","unstructured":"Ungprasert P, Suksaranjit P, Spanuchart I, Leeaphorn N, Permpalung N (2014) Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 44(1):63\u201367","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"6801_CR7","first-page":"461","volume":"55","author":"SK Rai","year":"2016","unstructured":"Rai SK, Choi HK, Sayre EC, Avi\u00f1a-Zubieta JA (2016) Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology (Oxford) 55(3):461\u2013469","journal-title":"Rheumatology (Oxford)"},{"key":"6801_CR8","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves J\u00fanior J, Shinjo SK (2023) Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review. Clin Rheumatol","DOI":"10.1007\/s10067-023-06633-5"},{"issue":"10","key":"6801_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-020-00942-3","volume":"22","author":"MC Mizus","year":"2020","unstructured":"Mizus MC, Tiniakou E (2020) Lipid-lowering therapies in myositis. Curr Rheumatol Rep 22(10):70","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"6801_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1468-3083.2011.04437.x","volume":"27","author":"H Wang","year":"2013","unstructured":"Wang H, Tang J, Chen X, Li F, Luo J (2013) Lipid profiles in untreated patients with dermatomyositis. J Eur Acad Dermatol Venereol 27(2):175\u2013179","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"6801_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1445-5994.2010.02406.x","volume":"42","author":"V Limaye","year":"2012","unstructured":"Limaye V, Hakendorf P, Woodman RJ, Blumbergs P, Roberts-Thomson P (2012) Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Intern Med J 42(2):191\u2013198","journal-title":"Intern Med J"},{"issue":"5\u20136","key":"6801_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1023\/B:CARD.0000015861.26111.ab","volume":"17","author":"S Franc","year":"2003","unstructured":"Franc S, Dejager S, Bruckert E, Chauvenet M, Giral P, Turpin G (2003) A comprehensive description of muscle symptoms associated with lipid-lowering drugs. Cardiovasc Drugs Ther 17(5\u20136):459\u2013465","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"6801_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, B\u00e9gaud B (2005) Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2013the PRIMO study. Cardiovasc Drugs Ther 19(6):403\u2013414","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"6801_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR et al (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63(3):713\u2013721","journal-title":"Arthritis Rheum"},{"issue":"7","key":"6801_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/clc.23375","volume":"43","author":"SS Bae","year":"2020","unstructured":"Bae SS, Oganesian B, Golub I, Charles-Schoeman C (2020) Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: a retrospective study. Clin Cardiol 43(7):732\u2013742","journal-title":"Clin Cardiol"},{"issue":"12","key":"6801_CR16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1136\/ard.2005.050377","volume":"65","author":"DH Solomon","year":"2006","unstructured":"Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S et al (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65(12):1608\u20131612","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6801_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/acr.23010","volume":"69","author":"MC Kwa","year":"2017","unstructured":"Kwa MC, Ardalan K, Laumann AE, Nardone B, West DP, Silverberg JI (2017) Validation of international classification of diseases codes for the epidemiologic study of dermatomyositis. Arthritis Care Res (Hoboken) 69(5):753\u2013757","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"6801_CR18","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3899\/jrheum.121302","volume":"40","author":"BM AkkaraVeetil","year":"2013","unstructured":"AkkaraVeetil BM, Myasoedova E, Matteson EL, Gabriel SE, Crowson CS (2013) Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol 40(7):1082\u20131088","journal-title":"J Rheumatol"},{"issue":"3","key":"6801_CR19","first-page":"296","volume":"27","author":"A Chhibber","year":"2021","unstructured":"Chhibber A, Hansen S, Biskupiak J (2021) Statin use and mortality in rheumatoid arthritis: an incident user cohort study. J Manag Care Spec Pharm 27(3):296\u2013305","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"6801_CR20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/acr.21643","volume":"64","author":"MA De Vera","year":"2012","unstructured":"De Vera MA, Choi H, Abrahamowicz M, Kopec J, Lacaille D (2012) Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study. Arthritis Care Res (Hoboken) 64(6):809\u2013816","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"6801_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/157016112799305021","volume":"10","author":"AL Catapano","year":"2012","unstructured":"Catapano AL (2012) Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin. Curr Vasc Pharmacol 10(2):257\u2013267","journal-title":"Curr Vasc Pharmacol"},{"issue":"9","key":"6801_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12325-011-0057-6","volume":"28","author":"M Eriksson","year":"2011","unstructured":"Eriksson M, Budinski D, Hounslow N (2011) Long-term efficacy of pitavastatin versus simvastatin. Adv Ther 28(9):799\u2013810","journal-title":"Adv Ther"},{"issue":"3","key":"6801_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/rap\/rkac102","volume":"6","author":"JR Hannah","year":"2022","unstructured":"Hannah JR, Gordon PA, Galloway J, Rutter M, Peach EJ, Rooney M et al (2022) Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics. Rheumatol Adv Pract 6(3):102","journal-title":"Rheumatol Adv Pract"},{"issue":"17","key":"6801_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s13075-015-0835-7","volume":"11","author":"JR Curtis","year":"2015","unstructured":"Curtis JR, Sarsour K, Napalkov P, Costa LA, Schulman KL (2015) Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor \u03b1 agents, a retrospective cohort study. Arthritis Res Ther 11(17):319","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06801-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06801-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T07:09:25Z","timestamp":1715670565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06801-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6801"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06801-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}